Skip to main content
. 2022 Jan 27;14(3):650. doi: 10.3390/cancers14030650

Figure 4.

Figure 4

Five-year patient survival post-transplant. TACE, transarterial chemoembolization; TKI, tyrosine kinase inhibitor; and n, number.